Skip to main content

Table 1 Criteria for inclusion and exclusion in the CapOpus trial.

From: Design paper: The CapOpus trial: A randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis

Inclusion:

Exclusion:

ICD-10 diagnosis F2 (F20–F29): Schizophrenia, schizotypal and delusional disorders

ICD-10 diagnosis F10.2: Alcohol dependence syndrome

 

ICD-10 diagnosis F11.2: Opioid dependence syndrome

ICD-10 diagnosis F12: Mental and behavioral disorders due to use of cannabinoids

ICD-10 diagnosis F14.2: Cocaine dependence syndrome

Aged 18–35 years

Refusal to give informed consent

Residence in the Copenhagen area

 

Sufficient Danish-speaking capabilities

 

Able and willing to give informed consent